Form 8-K - Current report:
SEC Accession No. 0001437749-22-021377
Filing Date
2022-08-26
Accepted
2022-08-26 08:00:27
Documents
15
Period of Report
2022-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20220825_8k.htm   iXBRL 8-K 25582
2 EXHIBIT 99.1 ex_416947.htm EX-99.1 10464
7 image01.jpg GRAPHIC 14098
  Complete submission text file 0001437749-22-021377.txt   191522

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blfs-20220825.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20220825_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20220825_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20220825_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT bioli20220825_8k_htm.xml XML 2581
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 221199615
SIC: 3845 Electromedical & Electrotherapeutic Apparatus